富瑞指，平安好医生(01833.HK) 把企业端(B端)数据重列，基于把企业供应链业务，即企业客户对药物及医疗器材的购买，重新分类至C端(个人客户)，引发可比较性忧虑。
该行认为，其他互联网公司与顶级医院合作，为平安好医生带来更大竞争，公司亦在健康管理服务上欠缺清晰的变现策略，维持对其“跑输大市”评级，目标价由4.8元上调至5.9元。(fc/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-08-21 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.